ADVFN US – Market Content Editor

Shares of Dayforce Inc. (NYSE:DAY) jumped more than 27% in premarket trading Monday, reaching $67.41, after reports surfaced that private equity firm Thoma Bravo (NYSE:TBA) is exploring a potential purchase of the human resources software company. The stock had closed at $52.88 previously. Sources indicate that talks are at an advanced stage, with a possible…

Oil prices inched higher on Monday as markets awaited a high-stakes meeting in Washington between U.S. President Donald Trump and Ukrainian President Volodymyr Zelensky, with traders weighing the potential impact on global supply. By 07:45 ET (11:45 GMT), October Brent crude futures rose 0.5% to $66.18 per barrel, while West Texas Intermediate (WTI) futures gained…

Morgan Stanley expects Nvidia (NASDAQ:NVDA) to deliver another set of robust results next week, even as expectations remain elevated. The firm lifted its price target to $206 from $200 and kept its Overweight rating in place, emphasizing confidence in the chipmaker’s growth trajectory through 2026. “We expect a strong quarter and outlook, but we’re a…

UnitedHealth Group Inc. (NYSE:UNH) extended its rebound Monday, climbing another 3% in premarket trading after soaring 12% on Friday. The surge followed revelations that Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.B) has taken a sizable stake in the health insurer. Regulatory filings show Berkshire acquired 5 million shares of UnitedHealth during the second quarter, a move…

Enlivex Therapeutics Ltd. (NASDAQ:ENLV) announced promising three-month outcomes from its Phase IIa study evaluating Allocetra in patients with moderate-to-severe knee osteoarthritis. The company’s stock surged 18% following the announcement. The randomized, double-blind, placebo-controlled, multi-center trial demonstrated a 24% reduction in knee pain and a 26% improvement in function across the modified intention-to-treat population treated with…

Madrigal Pharmaceuticals (NASDAQ:MDGL) fell 4% in pre-market trading Monday after the U.S. Food and Drug Administration granted approval to Novo Nordisk’s (NYSE:NVO) Wegovy for treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. The green light from regulators adds new competitive pressure for Madrigal, whose lead therapy Rezdiffra is also…

TeraWulf (NASDAQ:WULF) shares dropped 3% in early Monday trading, even as the company revealed that Google (NASDAQ:GOOGL) is raising its equity position in the Bitcoin mining and data center operator. The tech giant plans to lift its ownership to about 14%, up from roughly 8%, under the terms of a new CB-5 lease arrangement. As…

Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) surged 32% after the U.S. Food and Drug Administration provided positive responses during a pre-sNDA meeting regarding the potential at-home use of BXCL501 for managing agitation in patients with bipolar disorder or schizophrenia. The company announced that, based on feedback received from the FDA on August 14, 2025, it…

Gold prices inched higher on Monday, recovering from a more than two-week low as uncertainty over the Russia-Ukraine conflict persisted. At 04:55 ET (08:55 GMT), spot gold rose 0.4% to $3,348.30 an ounce, while October gold futures gained 0.3% to $3,393.97/oz. The yellow metal had dropped last week after U.S. President Donald Trump met with…

The U.S. dollar inched higher on Monday as markets braced for a week shaped by efforts to resolve the Ukraine conflict and the highly anticipated Federal Reserve Jackson Hole symposium. At 03:00 ET (08:00 GMT), the Dollar Index, which measures the greenback against six major currencies, rose 0.2% to 97.890 after last week’s 0.4% decline.…